無料プレビュー

Dr. Reddy's Laboratories Limited (RDY) · New York Stock Exchange

プロフィール

Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company developing, manufacturing, and marketing generic pharmaceuticals, active pharmaceutical ingredients, biosimilars, and consumer healthcare products. The company operates three reportable segments: Global Generics (generics, biosimilars, and OTC products across regulated and emerging markets); Pharmaceutical Services and Active Ingredients (APIs, intermediates, and contract manufacturing services); and Others (early-stage biotech and proprietary products). Core markets include the United States, India, Russia, Europe

主要指標

株価: $12.20 (-0.57%)
時価総額: 102億ドル
PER（今期予想）: 27.7
PBR: 2.6
配当利回り: 0.68%
52週レンジ: $11.36 – $15.67
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: New York Stock Exchange
構成銘柄: —

比較会社: TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、ZTS Zoetis Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.、CTLT Catalent, Inc.、ELAN Elanco Animal Health Incorporated

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-23 · 更新: 2026-10-09